Archives
-
Shufeng Xingbi Therapy in Allergic Rhinitis Rats
2026-09-14
This preprint examines how Shufeng Xingbi Therapy influences allergic rhinitis in rats through coordinated changes in nasal inflammation, Th1/Th2-associated signaling, gut microbiota, and short-chain fatty acids. Its main contribution is a gut–immune framework for interpreting a traditional medicine intervention, while its preclinical design and pre-peer-review status require cautious translation.
-
PTEN mRNA Nanoparticles Reverse Trastuzumab Resistance
2026-09-14
The reference study developed tumor-microenvironment-responsive nanoparticles for systemic delivery of PTEN mRNA, restoring a key brake on PI3K/Akt signaling in trastuzumab-resistant HER2-positive breast cancer. Its main practical contribution is a delivery strategy that combines circulation, tumor-selective activation, intracellular mRNA release, and pathway-level resensitization to antibody therapy.
-
Protease Inhibitor Cocktail for NPC Protein Assays
2026-09-13
Protect DHODH, TP53, and interaction partners from post-lysis proteolysis with a broad-spectrum workflow tailored to nasopharyngeal carcinoma research. This guide distinguishes EDTA-compatible immunoassays from metal-dependent workflows and provides practical preparation, optimization, and troubleshooting steps.
-
Oligo (dT) 25 Beads for mRNA Capture
2026-09-12
Oligo (dT) 25 Beads are superparamagnetic beads designed for selective polyA tail mRNA capture from eukaryotic samples. Their documented format supports eukaryotic mRNA isolation, direct first-strand cDNA synthesis, and downstream RT-PCR, sequencing, and hybridization workflows.
-
Tyrothricin: Membrane Biology and Assay Design
2026-09-11
Tyrothricin is a peptide antibiotic mixture best studied through integrated membrane, viability, and stress-response assays. This article connects antimicrobial mechanism analysis with mechanistic lessons from lens-cell iron biology to improve causal interpretation.
-
Phosbind Acrylamide for Protein Phosphorylation
2026-09-11
Phosbind Acrylamide is a phosphate-binding reagent for antibody-free SDS-PAGE phosphorylation detection. Its MnCl2-containing acrylamide formulation supports phosphorylation-dependent mobility analysis for protein targets in the 30–130 kDa range when used with a standard Tris-glycine running buffer.
-
Acetoacetic Acid Sodium Salt in Translational Research
2026-09-10
A mechanistic and strategic guide to using Acetoacetic acid sodium salt as a controlled ketone-body perturbation tool in energy metabolism research, diabetes metabolic imbalance studies, and translational assay development.
-
T-5224: C-Fos/AP-1 Logic in Neuroinflammation
2026-09-10
T-5224, a selective C-Fos/AP-1 inhibitor, offers a precise way to test transcriptional control of inflammatory outputs. This article connects its established arthritis evidence with the ATP–Ca2+–Piezo2 findings in trigeminal neuralgia while clearly separating validated results from testable hypotheses.
-
Temozolomide as a Translational DNA-Damage Tool
2026-09-09
Temozolomide is more than a cytotoxic benchmark: it is a mechanistically useful perturbation for connecting DNA damage, repair-state biology, ATRX status, and combination strategy in glioma research. This thought-leadership guide translates recent ATRX-deficient glioma findings into practical experimental and translational decisions.
-
Bone Transport, TGF-β1, and Diabetic Foot Ulcer Repair
2026-09-09
A 2026 rat study identifies TGF-β1/TGFBR1 signaling as a mechanistic link between bone transport, angiogenesis, immune regulation, and diabetic foot ulcer repair. The findings support pathway-focused follow-up experiments while emphasizing that pharmacological inhibition and translation to human wounds require careful validation.
-
ATRX Loss Sensitizes High-Grade Glioma to RTK Inhibitors
2026-09-08
The reference study identifies ATRX deficiency as a potential biomarker of increased sensitivity to multi-targeted receptor tyrosine kinase and PDGFR inhibitors in high-grade glioma models. Its combination experiments further suggest that pairing these inhibitors with temozolomide may produce stronger toxicity in ATRX-deficient cells, while supporting ATRX-aware interpretation of translational studies.
-
SB 202190: Practical p38 MAP Kinase Workflows
2026-09-08
Use SB 202190 as a cell-permeable p38 MAP kinase inhibitor to connect pathway modulation with cytokine output, viability, apoptosis, and stress signaling. This workflow also shows how to pair pharmacology with genetic and phospho-protein controls when studying RIPK1-dependent cell death.
-
Bone Transport, TGF-β1, and Diabetic Wound Repair
2026-09-07
The reference study identifies TGF-β1/TGFBR1 signaling as a mechanistic link between bone transport, angiogenesis, and immune regulation during ischemic diabetic foot ulcer repair. Its integrated animal, proteomic, molecular, and histological design suggests that bone transport may improve chronic wound healing through coordinated osteo-immune and vascular responses, while also defining important limits for translation.
-
Angiotensin I: Assay Design Beyond ACE Conversion
2026-09-07
Angiotensin I is more than a precursor of angiotensin II: it is a controllable substrate for studying renin-angiotensin system research, enzyme conversion, and cardiovascular phenotypes. This guide combines peptide biology with lessons from spectral-interference analysis to improve assay controls and interpretation.
-
EZ Cap™ Mouse IL-12 mRNA (m1Ψ): Reliable Assays
2026-09-05
This scenario-based guide shows how EZ Cap™ Mouse IL-12 mRNA (m1Ψ), SKU R1058, can support controlled mouse IL-12 expression, viability, proliferation, and cytotoxicity workflows. It connects transcript design, RNase-safe handling, assay controls, and emerging extrahepatic delivery evidence without overstating platform-specific findings.